797 related articles for article (PubMed ID: 25687306)
21. In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy.
Rojnik M; Kocbek P; Moret F; Compagnin C; Celotti L; Bovis MJ; Woodhams JH; Macrobert AJ; Scheglmann D; Helfrich W; Verkaik MJ; Papini E; Reddi E; Kos J
Nanomedicine (Lond); 2012 May; 7(5):663-77. PubMed ID: 22630150
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
Zheng B; Chen L; Pan CC; Wang JZ; Lu GR; Yang SX; Xue ZX; Wang FY; Xu CL
Nanomedicine (Lond); 2018 Apr; 13(7):769-785. PubMed ID: 29460671
[TBL] [Abstract][Full Text] [Related]
23. Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy.
Zheng Y; Zhang Y; Ao M; Zhang P; Zhang H; Li P; Qing L; Wang Z; Ran H
J Microencapsul; 2012; 29(5):437-44. PubMed ID: 22299595
[TBL] [Abstract][Full Text] [Related]
24. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
[TBL] [Abstract][Full Text] [Related]
25. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound-sensitive nanoparticle aggregates for targeted drug delivery.
Papa AL; Korin N; Kanapathipillai M; Mammoto A; Mammoto T; Jiang A; Mannix R; Uzun O; Johnson C; Bhatta D; Cuneo G; Ingber DE
Biomaterials; 2017 Sep; 139():187-194. PubMed ID: 28618348
[TBL] [Abstract][Full Text] [Related]
27. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
28. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
[TBL] [Abstract][Full Text] [Related]
29. Gas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugs.
Gaspar VM; Moreira AF; Costa EC; Queiroz JA; Sousa F; Pichon C; Correia IJ
Colloids Surf B Biointerfaces; 2015 Oct; 134():287-94. PubMed ID: 26209779
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
31. Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.
DU J; Sun Y; Li FH; DU LF; Duan YR
J Biosci; 2017 Jun; 42(2):299-309. PubMed ID: 28569253
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
[TBL] [Abstract][Full Text] [Related]
34. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.
Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM
J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372
[TBL] [Abstract][Full Text] [Related]
35. Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles.
Mohammadian F; Pilehvar-Soltanahmadi Y; Mofarrah M; Dastani-Habashi M; Zarghami N
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1972-1978. PubMed ID: 26772615
[TBL] [Abstract][Full Text] [Related]
36. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer.
Wu B; Liang Y; Tan Y; Xie C; Shen J; Zhang M; Liu X; Yang L; Zhang F; Liu L; Cai S; Huai D; Zheng D; Zhang R; Zhang C; Chen K; Tang X; Sui X
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():792-800. PubMed ID: 26652434
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid.
Ma Y; Sadoqi M; Shao J
Int J Pharm; 2012 Oct; 436(1-2):25-31. PubMed ID: 22692077
[TBL] [Abstract][Full Text] [Related]
38. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound contrast-enhanced imaging and in vitro antitumor effect of paclitaxel-poly(lactic-co-glycolic acid)-monomethoxypoly (ethylene glycol) nanocapsules with ultrasound-targeted microbubble destruction.
Ma J; Xing LX; Shen M; Li F; Zhu MJ; Jin LF; Li Z; Gao F; Su Y; Duan YR; Du LF
Mol Med Rep; 2015 Apr; 11(4):2413-20. PubMed ID: 25500683
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
